Product
Para-Aminosalicylic Acid
1 clinical trial
2 indications
Indication
TuberculosisIndication
Rifampicin-resistant TuberculosisClinical trial
A Multicenter, Randomized, Open-Label Study To Evaluate The Efficacy And Safety Of A Contezolid, Delamanid and Bedaquiline-Containing Short Regimen For The Treatment Of Rifampicin-Resistant Pulmonary TuberculosisStatus: Recruiting, Estimated PCD: 2026-10-01